Table 3 |
||||||
|
P. berghei oocyst number/mosquito and development stage proportions after a secondary, treated blood meal. |
||||||
|
Treatment |
Replication |
Stage of development* |
Total (CI95%) |
Examined mosquitoes |
||
|
|
||||||
|
s1 (%) |
s2 (%) |
s3 (%) |
||||
|
|
||||||
|
control |
1 |
25 (38) |
23 (37) |
12 (25) |
70 (50 - 98) |
27 |
|
2 |
15 (33) |
12 (31) |
13 (36) |
54 (42 - 70) |
92 |
|
|
|
||||||
|
NA 50 mg/kg |
1 |
10 (36) |
10 (36) |
8 (28) |
31 (19 - 49) |
23 |
|
2 |
30 (42) |
21 (33) |
11 (25) |
82 (68 - 100) |
112 |
|
|
|
||||||
|
AZA 50 mg/kg |
1 |
19 (34) |
20 (35) |
18 (31) |
61 (40 - 93) |
27 |
|
|
||||||
|
Secondary blood meals were carried out on mice treated with the indicated products and doses on day 7 after mosquito infection. Oocysts were evaluated on day 3 after the secondary blood meal (day 10 post infection). *s1: immature oocysts, before the formation of sporoblasts (fig. 1A); s2: immature oocysts, with visible sporoblasts and budding sporozoites (fig. 1 B1 - B2); s3: mature oocysts containing fully developed sporozoites (fig. 1C). Geometric means, only positive mosquitoes included. |
||||||
|
Lucantoni et al. Malaria Journal 2010 9:66 doi:10.1186/1475-2875-9-66 |
||||||